Identification of proapoptopic, anti-inflammatory, anti- proliferative, anti-invasive and anti-angiogenic targets of essential oils in cardamom by dual reverse virtual screening and binding pose analysis

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 6, 2013, Pages 3735-3742

  Bhattacharjee, Biplab ^a   Chatterjee, Jhinuk ^a  

^a PES UNIVERSITY   (India)

Author keywords

2D fingerprint based Reverse virtual; Cardamom; Eugenol; Reverse pharmacophore mapping; Screening

Indexed keywords

EID: 84882599736     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.6.3735     Document Type: Article

References (53)

1. Aggarwal BB, Shishodia S, Sandur SK, et al (2006). Inflammation and cancer: how hot is the link?. Biochem Pharmacol, 72, 1605-21.
2. al-Zuhair H, el-Sayeh B, Ameen HA, et al (1996). Pharmacological studies of cardamom oil in animals. Pharmacol Res, 34, 79- 82.
3. Aneja KR, Joshi R (2009). Antimicrobial activity of Amomum subulatum and Elettaria cardamomum against dental caries causing pathogens. Ethnobotanical Leaflets, 13, 840-9.
4. Bhattacharjee B, Vijayasarathy S, Karunakar P, et al (2012). Comparative reverse screening approach to identify potential anti-neoplastic targets of saffron functional components and binding mode. Asian Pac J Cancer Prev, 13, 5605-11.
5. Bianco C, Tortora G, Bianco R, et al (2002). Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa). Clin Cancer Res, 8, 3250-8.
6. Bruzzo J, Chiarella P, Fernández G, et al (2007). Systemic inflammation and experimental cancer in a murine model. Medicina (B Aires), 67, 469-74.
7. Chang HY, Yang X (2000). Proteases for cell suicide: functions and regulation of caspases. Microbiol Mol Bio Rev, 64, 821-46.
8. Chen YZ, Ung CY (2001). Prediction of potential toxicity and side effect protein targets of a small molecule by a ligandprotein inverse docking approach. J Mol Graph Model, 20, 199-18.
9. Ciardiello F, Caputo R, Borriello G, et al (2002). ZD1839 (IRESSA), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrugresistant MCF-7 ADR human breast cancer cells. Int J Cancer, 98, 463-9.
10. Delaquis PJ, Stanich K, Girard B, et al (2002). Antimicrobial activity of individual and mixed fractions of dill, cilantro, coriander and eucalyptus essential oils. Int J Food Microbiol, 74, 101-9.
11. de Jong JS, van Diest PJ, van der Valk P, et al (2001). Expression of growth factors, growth factor receptors and apoptosis related proteins in invasive breast cancer: relation to apoptotic rate. Breast Cancer Res Treat, 66, 201-8.
12. Driscoll JS (1984). The preclinical new drug research program of the National Cancer Institute. Cancer Treat, 68, 63-76.
13. Djenane D, Yangüela J, Montañés L, et al (2011). Antimicrobial activity of pistacia lentiscus and satureja montana essential oils against listeria monocytogenes CECT 935 using laboratory media: efficacy and synergistic potential in minced beef. Food Control, 22, 1046-53.
14. Duchen MR (2004). Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol Aspects Med, 25, 365-451.
15. Elder JT, Fisher GJ, Lindquist PB, et al (1989). Overexpression of transforming growth factor alpha in psoriatic epidermis. Science, 243, 811-4.
16. Elder LT, Klein SB, Tavakkol A, et al (1990). Growth factor and proto-oncogene expression in psoriasis. J Invest Dermatol, 95, 7-9.
17. Espina L, Somolinos M, Lorán S, et al (2011). Chemical composition of commercial citrus fruit essential oils and evaluation of their antimicrobial activity acting alone or in combined processes. Food Control, 22, 896-902.
18. Fang-jun L, Song-bai G, Chu-zhong L, et al (2008). Antitumor activity of F90, an epidermal growth factor receptor tyrosine kinase inhibitor, on glioblastoma cell line SHG-44. Chin Med J, 121, 1702-6.
19. Griffiths DE (2005). Psi-screen, an in vitro toxicity test system: applications in the bioassay of perfumes and fragrance chemicals. Altern Lab Anim, 33, 471-86.
20. Hajduk PJ, Huth JR, Tse C (2005). Predicting protein druggability. Drug Discov Today, 10, 1675-82.
21. Hamzaa R, Osman N (2012). Using of coffee and cardamom mixture to ameliorate oxidative stress induced in ?-irradiated rats. Biochemistry and Analytical Biochemistry, 1, 113-9.
22. Hashim S, Aboobaker VS, Madhubala R, Bhattacharya RK, Rao AR (1994). Modulatory effects of essential oils from spices on the formation of DNA adduct by aflatoxin B1 in vitro. Nutr Cancer, 21, 169-75.
23. Huang CM, Elmets CA, Tang DC, et al (2004). Proteomics reveals that proteins expressed during the early stage of Bacillus anthracis infection are potential targets for the development of vaccines and drugs. Genomics Proteomics Bioinforma, 3, 143-1.
24. Janne PA, Taffaro ML, Salgia R, et al (2002). Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma. Cancer Res, 62, 5242-7.
25. Ka H, Park HJ, Jung HJ et al (2003). Cinnamaldehyde induces apoptosis by ROS-mediated mitochondrial permeability transition in human promeolcytic leukaemia HL-60 cell. Cancer Lett, 196, 143-52.
26. Kinnings SL, Jackson RM (2011). ReverseScreen3D: a structurebased ligand matching method to identify protein targets. J Chem Inf Model, 51, 624-34.
27. Kinnings SL, Jackson RM (2009). LigMatch: a multiple structure-based ligand matching method for 3D virtual screening. J Chemical Information and Modeling, 49, 2056-66.
28. Kodama R, Noda K, Ide H (1976). Studies on the metabolism of d-limonene (p-mentha-1,8-diene). II: the metabolic fate of d-limonene in rabbits. Xenobiotica, 4, 85-95.
29. Kodama R, Yano T, Furukawa K, et al (1976). Studies on the metabolism of d-limonene (p-mentha-1,8-diene) IV: Isolation and characterization of new metabolites and species differences in metabolism. Xenobiotica, 6, 377-89.
30. Li H, Gao Z, Kang L, et al (2006). TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res, 34, 219-24.
31. Lin JH, Lu AY (1997). Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacol Rev, 49, 403-49.
32. Misharina T, Terenina M, Krikunova N (2011). Inhibition of 2-hexenal autooxidation by essential oils from clove bud, laurel, cardamom, nutmeg and mace. Chemistry and Chemical Technology, 5, 161-4.
33. Moteki H, Hibasami H, Yamada Y, et al (2002). Specific induction of apoptosis by 1,8-cineole in two human leukemia cell lines, but not a in human stomach cancer cell line. Oncol Rep, 9, 757-60.
34. Mangal M, Sagar P, Singh H, et al (2013). NPACT: naturally occurring plant-based anti-cancer compound-activity-target database. Nucleic Acids Res, 41, 1124-9.
35. Mitsuo Miyazawa, Masaki Shindo ,Tsutomu Shimada (2001). Oxidation of 1,8-Cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes. Drug Metabolism and Disposition, 29, 200-05.
36. Nagy M, Lacroute F, Thomas D (1992). Divergent evolution of pyrimidine biosynthesis between anaerobic and aerobic yeasts. Proct Natl Acad Sci, 89, 8966-70.
37. Nair S, Nagar R, Gupta R(1998). Antioxidant phenolics and flavonoids in common Indian foods. J Assoc Physicians India, 46, 708-10.
38. Nicholson D, Thornberry NA(2004). Caspase-3 and caspase-7. In 'Handbook of Proteolytic Enzymes', Eds Barrett AJ, Rawlings ND and Woessner JF, 2nd edn, Elsevier, London. 1298-2.
39. Padmakumari Amma KP, Rani MP, Sasidharan I, et al (2010). Chemical composition, flavonoid - phenolic contents and radical scavenging activity of four major varieties of cardamom. Int J Biol Med Res, 1, 20-4.
40. Persidis A (1998). Proteomics: an ambitious drug development platform attempts to link gene sequence to expressed phenotype under various physiological states. Nat Biotechnol, 16, 393-4.
41. Pons JL, Labesse G (2009). -TOME-2: a new pipeline for comparative modeling of protein-ligand complexes. Nucl Acids Res, 37, 485-91.
42. Rakoff-Nahoum S (2006). Why cancer and inflammation?. Yale J Biol Med Cancer, 79, 123-30.
43. Rawils J, Knecht W, Diekert K, et al (2000). Requirements for the mitochondrial input and localization of dihydroorotate dehydrogenase. Eur J Biochem, 267, 2079-87.
44. Raychaudhuri S (2010). How can we kill cancer cells: Insights from the computational models of apoptosis. World J Clin Oncol, 1 24-8.
45. Trott O, Olson AJ (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem, 31, 455-1.
46. Vermeulen K, Van Bockstaele DR, Berneman ZN (2003). The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif, 36, 131-49.
47. Watters D and Lavin M, Eds (1999). 'Signaling Pathways in Apoptosis' Hardwood Academic Publishers, Amsterdam, The Netherlands.
48. Wang JC, Chu PY, Chen CM, et al (2012). idTarget: a webserver for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach. Nucleic Acids Research, 40, 393-9.
49. Wang Y, Xiao J, Suzek TO, et al (2012). PubChem's BioAssay Database. Nucleic Acids Res, 40, 400-12.
50. Yadav VR, Prasad S, Sung B, et al (2010). Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Toxins (Basel), 2, 2428-66.
51. Ye H, Ye L, Kang H, et al (2010). HIT: linking herbal active ingredients to targets. Nucleic Acids Res, 39, 1055-9.
52. Zheng R, Chen TS, Lu T (2011). A Comparative Reverse Docking Strategy to Identify Potential Antineoplastic Targets of Tea Functional Components and Binding Mode. Int J Mol Sci, 12, 5200-12.
53. Zhou H, Beevers CS, Huang S (2011). Targets of curcumin. Curr Drug Targets, 12, 332-47.